💊 Fármacos A-Z 🧬 Dianas 🛠 Herramientas 📚 Guías
Todos los fármacos Clases de fármacos Áreas terapéuticas Efectos Secundarios
Guías Glosario Línea de tiempo
Comparaciones Recorridos de fármacos Familias farmacológicas
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sodium Glycerophosphate

CHEMBL6067979 Phase 4 Aprobado Unknown
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
216.0 g/mol
LogP
—
Phase
4

Sodium glycerophosphate is an organic phosphate salt used as a source of phosphorus and sodium in parenteral nutrition solutions, offering better compatibility with calcium-containing formulations than inorganic phosphate salts. It is slowly hydrolyzed by alkaline phosphatase to release inorganic phosphate, preventing precipitation with calcium in TPN admixtures. It is used to prevent hypophosphatemia in patients receiving total parenteral nutrition.

Peso molecular

216,0400 g/mol

TPSA

113,00 Ų

Áreas terapéuticas

Multiple Sclerosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

C(C(COP(=O)([O-])[O-])O)O.[Na+].[Na+]

InChI

InChI=1S/C3H9O6P.2Na/c4-1-3(5)2-9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;/q;2*+1/p-2

Molecular Formula

C3H7Na2O6P

HBD / HBA

2 / 6

Enlaces Rotables

3

Átomos Pesados

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Sodium glycerophosphate is an organic phosphate salt used as a source of phosphorus and sodium in parenteral nutrition solutions, offering better compatibility with calcium-containing formulations than inorganic phosphate salts. It is slowly hydrolyzed by alkaline phosphatase to release inorganic phosphate, preventing precipitation with calcium in TPN admixtures. It is used to prevent hypophosphatemia in patients receiving total parenteral nutrition.

Yes, Sodium Glycerophosphate is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067979. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 14754. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.